StudyFinder

I-InTERACT Preterm Parenting

RECRUITING

Many children born very preterm experience behavior problems, and existing resources for parenting these children are lacking. A pilot trial established the effectiveness of a preterm parenting intervention, I-Interact Preterm (I2P). This study proposes a three-arm randomized controlled trial (RCT) comparing the established seven-session I2P program, a microlearning delivery mode (I2P-Micro), and an internet resource comparison group (IRC). Outcomes will be assessed at pretreatment, post-treatment (12 weeks later), and at an extended follow-up six months post-randomization. These outcomes include parenting behaviors, child behavior problems, and parent distress. It is anticipated that both I2P and I2P-Micro will result in significant improvements relative to the IRC condition, with greater utilization expected in the I2P-Micro group.

I'm interested

ALL
3 years to 8 years old
This study is also accepting healthy volunteers

Inclusion Criteria:

  • Born at < 32 weeks gestational age.
  • Total T score of > 55 on the Child Behavior Checklist Total or Externalizing Behavior Scales OR Total T score of > 55 on the Eyberg Child Behavior Inventory total problem- or total intensity-scale.
  • English is the primary spoken language in the home.

Exclusion Criteria:

  • Is not 18 years or older.
  • Participant will be excluded from the study if the child does not reside with the caregiver at least half-time; the caregiving situation is not stable (i.e., there must be no scheduled custody hearings).
  • English is not the primary language spoken in the home.
  • Caregivers with a psychiatric hospitalization in the past year.

BEHAVIORAL: I-InTERACT Parenting Intervention (I2P) and coaching sessions, BEHAVIORAL: I-InTERACT Parenting Microlearning Intervention (I2P Micro) and coaching sessions, OTHER: Internet Resources

Child Behavior Problem, Preterm, Parent-Child Relations, Parenting

telehealth, online learning, microlearning

Zyah Flagg - zyah.flagg@cchmc.org
NA
NCT06767293
See this study on ClinicalTrials.gov

Back